Real-World Data (RWD): Unlocking Strategic Value for Clinical Research

Written by
Khalil Ben Yahia
Published on
10 Nov 25
Real-world data collection on your study
Real-World Data (RWD): Unlocking Strategic Value for Clinical Research
Key takeaways

Clinical evidence also comes from routine care.

Randomized controlled trials remain the reference for showing what a treatment achieves under ideal conditions. Real-World Evidence (RWE) shows how it performs in everyday practice, including in patients that trials may underrepresent, such as elderly patients or those with several conditions.

This guide helps sponsors, CROs, MedTech companies and research teams understand where real-world data comes from, how to make it reliable and how to build it into a study strategy. It is written for a device inventor running a first study as much as for an experienced research director.

Understanding RWD and RWE

Real-World Data (RWD) is data collected during routine care or daily life: electronic health records, patient registries, claims databases, connected devices and electronic patient-reported outcomes (ePRO).

Real-World Evidence (RWE) is the clinical evidence you obtain by analyzing that data.

Two concepts separate controlled trials from RWE. Efficacy measures what a treatment achieves in a controlled trial. Effectiveness measures what it achieves in real life, and RWE is what makes it measurable.

Inside the guide

You will find:

  • The main sources of real-world data, with their strengths and limits
  • The study designs that use RWD: observational studies, pragmatic trials, hybrid designs
  • The use cases for regulators, sponsors, clinicians and pharma or MedTech companies, including rare diseases
  • How the FDA, EMA and NMPA view RWE in submissions
  • The common pitfalls: heterogeneous data, missing data and bias, and how ePRO fills some of the gaps
  • The practices that make RWE reliable: standard vocabularies, OMOP and CDISC models, pre-specified protocols, RECORD reporting
  • The ethical rules and the role of technology, from cloud platforms to APIs
  • A method to integrate RWE into your research strategy, and a glossary of key terms

Why it matters

Payers and healthcare providers ask for evidence of a treatment's value across diverse populations, beyond a controlled setting. Wearables, telehealth and cloud platforms now make continuous data collection possible.

Real-world data comes with its own risks. Clinicians write health records for care, so the records often lack variables a study needs, such as disease severity or symptoms. Patients who receive one treatment may also differ from those who receive another, which distorts the comparison.

Regulators expect documented data provenance, an analysis plan set in advance and methods described in full, and their acceptance criteria vary from one country to another. The guide explains how to meet these expectations, and how ePRO adds the patient's own view to the data.

Download the free guide now

Real-world data collection on your study
See Datacapt on your own study
Whether you run a registry or an observational study, we show how you collect RWD with eCRFs and ePRO.
A 30-minute call on your protocol, your sites and the modules you need.

Frequently asked questions

Still have a question? Talk to our team.

Khalil Ben Yahia
Clinical Trials Expert

With over 10 years of experience working in CROs, Khalil brings deep expertise in clinical trials and a clear understanding of the daily challenges faced by research professionals. His insights are grounded in real-world operations, making his perspective both practical and strategic.